186 related articles for article (PubMed ID: 36517571)
1. Molecular and metabolic alterations of 2,3-dihydroquinazolin-4(1H)-one derivatives in prostate cancer cell lines.
Dahabiyeh LA; Hourani W; Darwish W; Hudaib F; Abu-Irmaileh B; Deb PK; Venugopala KN; Mohanlall V; Abu-Dahab R; Semreen MH; Bustanji Y
Sci Rep; 2022 Dec; 12(1):21599. PubMed ID: 36517571
[TBL] [Abstract][Full Text] [Related]
2. Mass spectrometry-based metabolomics approach and in vitro assays revealed promising role of 2,3-dihydroquinazolin-4(1H)-one derivatives against colorectal cancer cell lines.
Dahabiyeh LA; Hudaib F; Hourani W; Darwish W; Abu-Irmaileh B; Deb PK; Venugopala KN; Mohanlall V; Chandrashekharappa S; Abu-Dahab R; Semreen MH; Bustanji Y
Eur J Pharm Sci; 2023 Mar; 182():106378. PubMed ID: 36638899
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
[TBL] [Abstract][Full Text] [Related]
4. [Effects of the Rho-kinase inhibitor fasudil on the invasion, migration, and apoptosis of human prostate cancer PC3 and DU145 cells].
Gao QQ; Chen H; Chen Y; Xu ZP; Zhu LL; Yu W; Han YF; Dai YT
Zhonghua Nan Ke Xue; 2016 Jun; 22(6):483-490. PubMed ID: 28963834
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, Anticancer Activity on Prostate Cancer Cell Lines and Molecular Modeling Studies of Flurbiprofen-Thioether Derivatives as Potential Target of MetAP (Type II).
Yılmaz Ö; Bayer B; Bekçi H; Uba AI; Cumaoğlu A; Yelekçi K; Küçükgüzel ŞG
Med Chem; 2020; 16(6):735-749. PubMed ID: 31203805
[TBL] [Abstract][Full Text] [Related]
6. LC-MS metabolomic evidence metabolites from Oenothera rosea L´ Hér. ex Ait with antiproliferative properties on DU145 human prostate cancer cell line.
Márquez-Flores YK; Estrada-Pérez AR; Velasco-Quijano JS; Molina-Urrutia ZM; Rosales-Hernández MC; Fragoso-Morales LG; Meléndez-Camargo ME; Correa-Basurto J
Biomed Pharmacother; 2023 Sep; 165():115193. PubMed ID: 37517287
[TBL] [Abstract][Full Text] [Related]
7. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
Li L; Zhu Z; Joshi B; Porter AT; Tang DG
Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative effect, alteration of cancer cell cycle progression and potential MET kinase inhibition induced by 3,4-dihydropyrimidin-2(1H)-one C5 amide derivatives.
Moosavi F; Ebadi A; Mohabbati M; Damghani T; Mortazavi M; Miri R; Firuzi O
Eur J Pharmacol; 2021 Mar; 894():173850. PubMed ID: 33428899
[TBL] [Abstract][Full Text] [Related]
9. CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells.
Arisan ED; Obakan P; Coker-Gurkan A; Calcabrini A; Agostinelli E; Unsal NP
Curr Pharm Des; 2014; 20(2):180-8. PubMed ID: 23701543
[TBL] [Abstract][Full Text] [Related]
10. Tetrandrine suppresses proliferation, induces apoptosis, and inhibits migration and invasion in human prostate cancer cells.
Liu W; Kou B; Ma ZK; Tang XS; Lv C; Ye M; Chen JQ; Li L; Wang XY; He DL
Asian J Androl; 2015; 17(5):850-3. PubMed ID: 25677131
[TBL] [Abstract][Full Text] [Related]
11. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
[TBL] [Abstract][Full Text] [Related]
12. (3,3'-Methylene)bis-2-hydroxy-1,4-naphthoquinones induce cytotoxicity against DU145 and PC3 cancer cells by inhibiting cell viability and promoting cell cycle arrest.
de Freitas PP; Ribeiro RCB; Dos Santos Guimarães I; Moreira CS; Rocha DR; de Carvalho da Silva F; Ferreira VF; Gimba ERP
Mol Biol Rep; 2021 Apr; 48(4):3253-3263. PubMed ID: 34009563
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative and apoptosis-inducing activity of novel 3-substituted-3-hydroxy-2-oxindole compounds.
Nazemi Moghaddam M; Jalal R; Zeraatkar Z
In Vitro Cell Dev Biol Anim; 2018 Jan; 54(1):61-70. PubMed ID: 29124512
[TBL] [Abstract][Full Text] [Related]
14. [Influence of SOX10 on the proliferation and invasion of prostate cancer cells].
Tang X; Zhao WH; Song QQ; Yin HQ; DU YQ; Sheng ZZ; Wang Q; Zhang XW; Li Q; Liu SJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Aug; 50(4):602-606. PubMed ID: 30122756
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of C
Guggilapu SD; Lalita G; Reddy TS; Prajapti SK; Nagarsenkar A; Ramu S; Brahma UR; Lakshmi UJ; Vegi GMN; Bhargava SK; Babu BN
Eur J Med Chem; 2017 Mar; 128():1-12. PubMed ID: 28131777
[TBL] [Abstract][Full Text] [Related]
17. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Res Commun Mol Pathol Pharmacol; 2004; 115-116():251-64. PubMed ID: 17564322
[TBL] [Abstract][Full Text] [Related]
19. [Design, synthesis and antiproliferative activity in cancer cells of novel 18β-glycyrrhetinic acid derivatives].
Huang M; Li K; Jin SY; Cui TX; Liu D; Zhao LX
Yao Xue Xue Bao; 2015 Oct; 50(10):1263-71. PubMed ID: 26837172
[TBL] [Abstract][Full Text] [Related]
20. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
Barrett CS; Millena AC; Khan SA
Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
